natasha holder, md, msc. pgy-1. osteonecrosis of the femoral head ◦ etiology, pathogenesis ...
TRANSCRIPT
Osteonecrosis of the Hip: Diagnosis and Management of
Ficat I and II
Natasha Holder, MD, MSc.PGY-1
Osteonecrosis of the femoral head◦ Etiology, Pathogenesis
Clinical Presentation Diagnosis Classification of AVN Management of Stage I and Stage II
◦ Non-Operative◦ Core Decompression◦ Bone Grafting◦ Osteotomy
Overview
AKA avascular necrosis or aseptic necrosis Disruption of the blood flow to the femoral
head (traumatic or nontraumatic) Commonly affects patients between 20 and
50 years of age Ultimate goal of treatment of ON of the hip
is preservation of the femoral head
Osteonecrosis of the Femoral Head
Trauma Corticosteroid use Alcohol abuse Smoking Sickle cell anemia Coagulopathies Systemic lupus erythematosus Hypercholesterolemia Organ Transplantation
Risk Factors for Osteonecrosis
JAAOS, 1999:250-261
Gaucher Disease Caisson Disease Radiation Therapy Arterial disorders Intramedullary hemorrhages Chronic Pancreatitis Hypertriglyceridemia HIV
Risk Factors for Osteonecrosis
JAAOS, 1999:250-261
Early in the disease process, the condition is painless
Chief complaint is pain Localized to the groin area, but it may also
manifest in the ipsilateral buttock, knee, or greater trochanteric region.
Painful symptoms are usually exacerbated with weight bearing but are relieved by rest
Clinical Presentation
History ◦ High index of suspicion◦ Risk factors◦ Groin pain, night pain
Physical Exam◦ Pain on internal rotation◦ Pain with active and passive ROM◦ Decreased ROM ◦ Antalgic gait◦ Examine the contralateral hip
Diagnosis
Laboratory tests◦ R/O systemic disease, coagulopathies
Radiological Tests◦ Plain film - AP and Frog leg lateral
Cysts, sclerosis or a crescent sign Crescent sign results from subchondral collapse of the
necrotic segment◦ MRI – Diagnostic Standard◦ Bone Scan
Special Tests◦ Bone marrow pressure, venography, biopsy
Diagnosis
Ficat and Arlet Classification
Non-operative Treatment Operative Treatment
◦ Core decompression◦ Non-vascularized bone-grafting◦ Vascularized bone-grafting◦ Osteotomy◦ Limited Femoral Resurfacing Arthroplasty◦ Total Hip Arthroplasty
Treatment of Osteonecrosis Non-operative Treatment Operative Treatment
◦ Core decompression◦ Non-vascularized bone-grafting◦ Vascularized bone-grafting◦ Osteotomy
Restricted weight bearing is NOT an treatment option except in small, asymptomatic lesions outside the weight bearing area
Meta analysis of outcomes of protected weight bearing in 819 patients demonstrated a failure rate >80 % at a mean of 34 months (Mont et al. Clin Orth Relat Res, 1996:169-78)
Non-Operative Treatment
Pharmacological agents: lipid-lowering drugs, anticoagulants, vasodilators and bisphoshonates
Prichett et al. report at a mean of 7.5 years, ON of the femoral head has developed in only 1% of 284 patients who were taking high dose steroids and a statin. (Clin Orthop 2001; 386:173-8)
Non-Operative Treatment
Glueck et al. used enoxaparin (60mg/day for 12 weeks) to treat patients with thrombophillic or hypofribinolytic disorders in early stages of ON
At 2 years, 89% (31/35 hips) had not required surgery and remained at the Ficat I or II stage (Clin Orth Relat Res, 2005:164-70)
Non-Operative Treatment
Bisphosonates inhibit osteoclast activity and thus curtail bone reabsorption
Agarwala et al. first reported the efficacy of bisphosphonates. Showed an improvement in Harris hip scores, retarded progression of of the disease and reduced rate of collapse (Rhemat. 2005:353-59)
Non-Operative Treatment
Agarwala et al.◦ prospective study ◦ 395 hips treated with 10 mg alendronate/day◦ F/U 1-8 years◦ 92% had a satisfactory result (no surgical
intervention)◦ Patients had improvement in clinical function, a
reduction in rate of collapse and a decreased requirement for THA
◦ Improvement is marked if treatment is begun in the pre-collapse stages
Non-Operative Treatment
Goal: to decompress the femoral head and reduce the intraosseous pressure
No general agreement on indications or technique
Substantial differences in success rates reported◦ poor staging of patient pathology◦ recurrent insults depending on pathology◦ variations in techniques
Core Decompression
Originally employed by Ficat and Arlet to obtain histological specimens
Decompression reduced bone marrow pressure allowing restoration of blood flow
Stulberg et al. (Clin Orthop 1991, 268:140-51)◦ Prospective, randomised study, 55 hips◦ 70% success by Harris Hip score with Ficat I, II, or III stage
Koo et al. (JBJS 1995, 77:870-74) ◦ Randomised control trial, 37 hips◦ Operative Group: 72% progression and 72% of those that
progressed required THA◦ Non-Operative group: 79% progression and 68% required THA
Core Decompression
Retrospective studies have shown that results of core decompression were substantially worse when there had been collapse of the femoral head preoperatively
Smith et al. (JBJS 1995, 77:674-80)◦ Retrospective review of 114 hips◦ Decrease in success rate if the crescent sign had
been present◦ 80% success rate for Ficat I, 20% If crescent sign
was present, 0% femoral head collapse
Core Decompression
Rationale:1. Decompress the femoral head2. Removal necrotic bone3. Replacement with autogenous cancellous bone4. Support the subchondral bone with a strong and
viable bone strut5. Revascularization the femoral head
Vascularized Bone Grafting
Vascularized Bone Grafting
Urbaniak et al. (JBJS 1995; 77:681-94)
◦ 103 hips, Mean F/U 7 years◦ Best results were seen in those with small or medium
precollapse lesions.◦ 11% (2/19) of pre-collapse group were converted to THA◦ 23% (5/22) of post-collapse group were converted to THA◦ 39% (24/62) of advanced lesion group were converted to THA
Berend et al. (JBJS 2003; 85:987-93)
◦ 224 collapsed hips◦ 64.5% survival rate at a mean 4.3 years (range 2-12)◦ Relative risk of conversion to THA was associated with an
increased lesion size and the amount of collapse
Vascularized Bone Grafting
Provides decompression of the femoral head, removal of necrotic bone and structural support and scaffolding to allow repair and remodeling of subchondral bone
3 distinct approaches 1. Core tract grafting2. Femoral Neck Window - Light bulb procedure.3. Trapdoor through articular cartilage of head
Nonvacularized Bone Grafting
Nonvacularized Bone Grafting
Lieberman et al. 2002; 84:834-853
Nonvacularized Bone Grafting
Meyers et al; JBJS 1973:55A,pg 257
Rosenwasser et al. (Clin Orthop. 1994:306:17-27)
◦ Described the “light bulb” approach◦ 87% success rate in a study of 15 hips with a
mean F/U of 12 years
Mont et al. (Clin Orthop. 2003: 417:84-92)
◦ 86% success rate in a study of 21 hips, light bulb approach
◦ Harris score >80 and no additional procedures
Nonvacularized Bone Grafting
Lieberman et al. (Clin Orthop 2004: 429:139-45)
◦ Retrospective study, 17 hips, Core track method◦ Used bone morphogenic protein◦ 14/17 successful result◦ Harris score >80 and no conversion to THA
Nonvacularized Bone Grafting
To remove necrotic or collapsing segment from the principle weight-bearing region
Replace this area with a segment of articular cartilage of the femoral head that is supported by healthy, viable bone
2 Types:
◦ Transtrochanteric Rotational Osteotomies
◦ Intertrochanteric varus/valgus Osteotomies
Osteotomy
Sugioka et al.◦ 78% of the 295 hips studied had a successful
outcome at a mean of 11 year F/U
Masuda et al.◦ 69% of 52 hips studied had a successful outcome
at a mean of 5 year F/U
Rotational Osteotomy
Best results in young active patients who were not taking corticosteroids, had unilateral involvement with a good preoperative range of hip motion, and had a small lesion without femoral head collapse
Rotational Osteotomy
Less technically demanding Commonly used in Europe with varying
success
Intertrochanteric Osteotomy
Merle d’Aubigne et al. ((JBJS(br), 1965; 47:612-33)
◦ Good to excellent pain reduction in 79% of the 75 hips with Ficat II or III. F/U 1 to 6 years.
Mont et al. (JBJS, 1996; 78:1032-38)
◦ Good to excellent Harris hip scores in 76% of the 37 hips studied after treatment with varus osteotomy. F/U mean 11.5 years
Intertrochanteric Osteotomy
Drescher et al. (JBJS (Br) 2003;85-B:969-74)
◦ 70 intertrochanteric flexion osteotomies. ◦ The mean follow-up was 10.4 years (3.0 to 20.3). ◦ The overall mean Harris hip score increased from 51
points preoperatively to 71 points postoperatively.◦ A total of 19 hips (27%) underwent total hip arthroplasty
at a mean of 8.7 years after osteotomy.◦ The five-year survival rate was 90%.
◦ Flexion osteotomy is a safe and effective procedure in Ficat stage 2 and 3, preferably with a necrotic angle of <200°
Intertochanteric Osteotomy
The size of the osteonecrotic lesion was determined to be a critical factor in the rate of success of the osteotomy
Intertochanteric Osteotomy
Stage Treatment
I (no radiographic changes) Non-Operative, Core Decompression
II ( precollapse) Core decompression, Bone grafting, osteotomies
Management of Ficat I and II
The etiology of ON of the hip may have a genetic basis
The interaction between certain risk factors and a genetic predisposition may determine the course of ON in a particular individual
The role of biological agents in altering the natural history of ON remains to be elucidated
Early diagnosis and intervention prior to collapse is key to successful outcomes of joint preserving procedures
Summary